FORUM GIOVANI RICERCATORI

 GIOVEDÌ 16 NOVEMBRE 2023

14.15 – 14.30 Introduzione al Corso

14.30 – 15.00 Lettura magistrale: “IDEARE E REALIZZARE UN PROGETTO DI RICERCA”, S.Cucchiara

15.00 – 16.30 Workshop 1

Moderatori: M. Deganello Saccomani, S. Oliva

Presentazione di 7 lavori (10 minuti di esposizione + 5 minuti di discussione)

Impaired intestinal permeability in pediatric patients with juvenile idiopathic arthritis, Sivia Amati (Bari)

A multicenter retrospective study on thromboembolism in children with inflammatory bowel diseases, Carolina Arsani (Bologna)

From the Birth to the Weaning: a Window of Opportunity for the Microbiota’s Infants, Valentina Biagioli (Genova)

The impact of Crohn’s disease exclusion diet (CDED) combined with partial enteral nutrition (PEN) on nutritional status and mucosal inflammation of children with Crohn’s disease: a six months single-center experience, Francesco Pellegrino (Torino)

Uncommon neurological events of thalidomide in inflammatory bowel disease, Rossella Morello (Messina)

Accuracy of non-invasive diagnostic tests for pediatric helicobacter pylori infection, Tonia Rosa (Roma)

Clinical presentation of celiac disease: experience of Italian centre, Anna Pia Delli Bovi (Roma)

16.30 – 17.00 LEADERSHIP: cosa vuol dire?

17.00 – 17.15 Coffee Break

17.15 – 18.45 Workshop 2

Moderatori: S. Salvatore, R. Tambucci

Presentazione di 7 lavori (10 minuti di esposizione + 5 minuti di discussione)

Diagnostic delay of celiac disease in childhood: an Italian multicenter cross-sectional retrospective study, Giovanni la Grasta (Bari)

IBAT inhibitor for the treatment of patients with Progressive Familial Intrahepatic Cholestasis: a single Centre experience, Martina Vecchi (Monza)

Effectiveness and safety of switching to subcutaneous infliximab in pediatric IBD patients on estrablished biosilimar infliximab maintenance therapy: real world data from a single-centre cohort , Laura Gianolio (Milano)

Screening of psychosocial dysfunctions in pediatric patients with Eosinophilic Esophagitis: a pilot study, Flaminia Ruberti (Parma)

Broad spectrum antibiotics and effect of Lacticaseibacillus rhamnosus GG (ATCC 53103) on enteric neuromuscular function in mice, Chiara Morreale (Varese)

An asymptomatic child with an unusual accumulation, Giuseppina Bernardo (Napoli)

Safety and feasibility of EUS-guided, PEG-J-based conservative management of SMA syndrome: a prospective observational study in a pediatric tertiary center, Chiara Imondi (Roma)

18.45 – 19.15 LEADERSHIP: Parlare in pubblico

19.15 Chiusura dalla prima giornata

VENERDÌ 17 NOVEMBRE 2023

9.00 – 9.30 LEADERSHIP: cosa la guida?

Parte 1 (Valori e Contesto)

9.30 – 11.00 Workshop 3

Moderatori: R. Francavilla, C. Strisciuglio

Presentazione di 7 lavori (10 minuti di esposizione + 5 minuti di discussione)

Severe kidney involvement due to vedolizumab in a pediatric patient affected by very early onset inflammatory bowel disease, Silvana Ancona (Genova)

The prevalence of constipation and the role of macrogol in children with Inflammatory Bowel Disease (IBD): a multicenter, retrospective study, Antonio Colucci (Napoli)

Helicobacter pylori infection in newly Inflammatory Bowel Disease pediatric patients: a prospective multicentre study, Marisa Piccirillo (Roma)

Role of MIRNA-21 and MIRNA-223 in children with eosinophilic esophagitis, Daniela Simonetti (Napoli)

Foreign body ingestions in children: a 16-year experience, Andrea Di Siena (Udine)

Impact of CFRT modulator therapy on inflammation parameteres in patients with cystic fibrosis: a single-center retrospective study, Angela Pepe (Salerno)

Dupilumab in pediatric Eosinophilic Gastrointestinal Diseases, Francesca Bravin (Pisa)

11.00 – 11.15 Coffee break

11.15 – 11.45LEADERSHIP: Cosa la guida?

Parte 2 (Empatia, comunicazione e ascolto)

11.45 – 13.15 Workshop 4:

Moderatori: A. Di Giorgio, C. Romano

Presentazione di 7 lavori (10 minuti di esposizione + 5 minuti di discussione)

Effects of CFTR-modulator therapy on chronic liver disease and liver stiffness: a single center experience, Elisabetta Augostoni (Torino)

The spectrum of intestinal epithelial alterations in children with Down Syndrome: celiac disease or non-celicalc gluten sensitivity?, Roberta Rotondo (Parma)

Characterization of pediatric Eosinophilic gastrointestinal diseases (EGIDs) in a large multicenter cohort, Selene Del Vespa (Firenze)

Nocturnal Infant Crying Evaluation (NICE) Study: looking for a hallmark of reflux disease in infants, Greta Carabelli (Varese)

Analysis of different endotypes of eosinophilic esophagitis in an international cohort of pediatric patients from the European EuroPEER registry, Vanessa Sassano (Roma)

Surgery in high-risk paediatric Crohn’s Disease treated with up-front anti-TNF agents and long-standing biologic therapy, Filippo Mondì (Roma)

The prevalence of Irritable Bowel Syndrome (IBS) among children and adolescents with Inflammatory Bowel Disease (IBD), Simona Salomone (Napoli)

13.15 – 14.15 Lunch

14.15 – 14.45 LEADERSHIP: gestire i gruppi di lavoro

14.45 – 15.45 Letture sulla metodologia e ricerca

Focus su:

– Come fare una ricerca bibliografica, M. Baldassarre

– Come leggere un Position Paper, R. Francavilla

15.45 – 16.00 Coffee break

16.00 – 17.00 Lavori in gruppi: seconda parte

Gruppo 1

Gruppo 2

Gruppo 3

Gruppo 4

17.00 – 17.15 Chiusura della seconda giornata

SABATO 18 NOVEMBRE 2023

9.00 – 10.30 LEADERSHIP: costruire il proprio piano d’azione

10.30 – 10.45 Coffee break

10.45- 12.30 Discussione aperta tra partecipanti ed esperti

12.30 – 12.45 Conclusione e chiusura dei lavori